Cancer is a major public health problem worldwide and finding a total cure or eradication of the disease has been the expectations of medical researchers and medical practitioners in the recent times. In this paper, invasion of normal cells by carcinogens is considered. The purpose of the research is to study the dynamic evolutions of cancer and immune cells with the view finding most effective strategic way to control or eradicate cancer growth in human beings. We proposed five growths and mitigate models for benign and malignant cancer which are coupled ordinary differential equations and partial differential equations and Numerical simulations are made for the models. Analytic and Numerical solutions and sensitivity analysis of the models to parameters are obtained. It is found that the benign and malignant cancer cells displayed out of control growth and hence unstable in nature and the immune cells depreciated to the point of immune collapse. By the use of energy function it is established that staving of cancer cells of oxygen or use of drugs are strategic ways of combating cancer disease. Moreover, if the cancer cells are starved of basic nutrients or some basic enzymes inhibited it is expected that similar effect can also be achieved. The starvation of cancer cells should focus on oxygen, nutrients and vital enzymes. However, it is hoped that drugs developers and bioengineers will come up with means to achieve the starvation strategies to combat cancer disease.
and the non-Hodgkin lymphoma are major killers ( [1] [3] ).
Finding a total cure or eradication of cancer disease has been the focal point of most medical researches and the expectations of medical practitioners in the recent times. The dynamic behaviour of cancer cells is complex and stochastic in nature. Combating the disease will require thorough understanding of the formation of cancer and the spread of disease in the blood circulation and lymph systems.
Scientists have been employing the multi-agent modelling techniques to simulate cancer models. The essence of simulations is to explore decision support tools for better understanding of complexity surrounding the cancer's proliferation, strategies to combat it and to possibly predict treatment options.
Several researches were pioneered to understand tempo-spatial dynamics of the tumour cells and the best strategic way of combating them ( [4] [5] [6] [7] [8]). In order to understand the dynamics of the formation, propagation and treatment of cancer; many investigations have been conducted at the atomic and cellular levels. From genetic mutational point of view, tumours are formed as a result of genetic mutation which gives rise to abnormal DNA as a result of mismatched pair of genes ( [9] [10]). The growth of the tumours can be controlled at various time scales. The scales of description of cancer research are at the sub-cellular, cellular and tissue levels or in the whole organ in the body (Macro scale) ( [8] [11] ).
Considerable advances were made in the study of blood flow in the circulatory system using mathematical analysis and simulation. The use of multi-scale models for simulation of cancer growth and treatment options have been revolutionised ( [12] [13] [14] ). Many researches were on how to understand the dynamics of cancer evolution from sub-cellular to cellular to tissue levels and the whole organ level using the multi-agents interacting at various time and spatial scales ( [12] (tumour and diffusion in living organism) and some were in vitro specifically targeted on cultured cell colonies, concentrated on the growth and control drugs ( [9] ). There are now mathematical models to optimised cancer therapy in the literature ( [7] [8] [14] ).
Konstantina and Franziska ( [19] ) simulated a model on evolution of tumours under the influence of nutrient and drug application. Neurosurgical simulation of skull base tumours has been made (see [20] ) using a 3D printed rapid prototyping model. A fast Graphic Processing Unit (GPU) based Radio Frequency Ablation (RFA) solver was developed to predict the lesion and the solver take less than 3 min for treatment duration of 26 min. Moreover, when the model was simulated using patient-specific input parameters, it was found that the deviation between real and predicted lesion was below 3 mm ( [21] ).
Simple ordinary differential equations of tumour and angiogenic radiation treatment are extensively found in the literature. We will mention, in particular, the work of ( [14] ) in which ODEs were used to study the interplay between tumours and neovascular therapy, tumour vascularization and growth using diffusion models ( [16] In this paper, the motivation for the study is the following question "is it possible to retard the growth/eliminate the malignant cancer in a patient by starving the cancer of nutrients or oxygen?" To answer the question, four benign cancer and one malignant cancer models incorporating immune cells are proposed to study the growth of cancer cells and the immune cells. Our research interest is to determine which strategic way of retarding the growth of the cancer.
To be specific, our goal is to use starvation strategy to control the malignant cancer cells in body of patient. We make use of some coupled ordinary differential equations and partial differential equations; develop energy function and numeric simulations for the models used.
Preliminaries and Statement of the Problem
We will consider four benign cancer and one malignant cancer models together The following preliminary treatments are essential to our study.
Pollutants and Carcinogenic Effect
The pollutants enter the body through the alimentary canal, breathing system or through the skin. Some pollutants released into the environment through hu- 
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Methods
In the models we will consider ( ) Throughout this paper cancer and tumour will be used interchangeably. By tumour we mean benign cancer whereas by cancer we mean malignant cancer.
Cancer Growth with Oxygen Depletion Model
We consider cancer multiplicative model as follows ( )
where ( ) N t is the population of tumour cells at time t and ( ) C t is the concentration of oxygen at time t; k is the natural growth rate of the cancer cell, β is the natural death rate of the cell. We will consider various forms for
investigating the behaviour of tumour and immune cells without consideration given to the contribution of oxygen to the behaviour of the dual population.
Case I:
that is, exponential growth situation, therefore the Equation (1) becomes 
t t t t t t t j
In view of the fact that we have not lay our hands on clinical data to calibrate our models. To determine the population tumour cells with immune cells such as cytokines, β-Lymphocytes and T-Lymphocytes, in view of no specific clinical input parameter we will assign values to the parameters as follows:
Therefore, the Equation (3) becomes 
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The equilibrium points for the Equation (4) are set of points in
t r t r t = = = =
Case II: when the growth is quadratic in nature, that is,
That is the tumour cell is localised to a point but not spreading along the blood and lymphatic vessels (benign) situation. In this case, the Equation (1) becomes ( ) (
If we will substitute 
If we impose the given parameter values and the initial condition, we get the following differential equations: 
The equilibrium points for the Equation (4) are set of points in ( ) 
By making the substitution 
The equilibrium points for the Equation (10) are set of points in ( )
Case V: Malignant cancer situation with immune replenishment and oxygen supply to the cells ( )
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where 0 v the velocity of conviction of oxygen, 1 k is constant due to mass action between oxygen molecules and the haemoglobin in the blood. ( ) , r t x is number of haemoglobin in the blood at time t measured at distance x from source. D is diffusion coefficient of oxygen to the blood. 2 k is net association of oxidised blood and n is the Hill's constant. γ is chemotherapy constant and 
Results and Discussion
Finding analytic solutions to the models we will consider are generally difficult, even though, the solution can be shown to exist in some given interval. Moreover, using symbolic programming one will find out that the solutions of the models are complicated that one cannot even attach a meaning to the result obtained. For this reason, we decided make use of the built Runge-Kutta code in the Maple software to simulate our models. Runge-Kutta methods are well known for having desirable computational properties such as convergence and stability. From our choice of parameters and all the graphs plotted, the models In order to investigate the behaviour of the cancer cells together with the immune cells, we will carry out numerical simulation to the models. The multi-agents models we considered are complex and the analytic solutions not easily obtainable; hence, we make use of Maple 2017 to simulate and obtain symbolic and numeric solutions to the models.
In Figure 3 In Figure 4 , the cancer cells in the benign case possess exponential growth. In Table 1 , we obtained the numerical solution to the model in the Equation (4) using the initial data ( ) 
Then we obtain the numerical solution to the Equation (1), see Table 1 using the maple code (see Appendix).
The corresponding graph to the solutions to the tumour model in the Equation (10) is shown in Figure 5 it is observed that the tumour cells continue to grow in the presence of immune cells. The simulation shows that at 1.7 t = hour the solution to the system has singularity. When we consider the case when time is very greater than 1.7 t = , the behaviour of the cells is shown in Figure 6 .
In Figure 6 , the first plot is the growth of tumour cell. The first plot at top by right is the behaviour of immune cell ( ) 1 r t , the second one is for ( ) In Figure (7) as follows.
The graphic display of Table 2 is in Figure 7 .
In Figure 7 and Figure 8 the population of the tumour cells continues to grow while the immune cells continue to deplete. The solution to model has singularity at the period
hence it is very difficult to predict the behaviour of the model in a small region where singularities occurred.
The numerical solution to ordinary differential equations in the Equation (10) is given in Table 3 .
The plot of the graph to the solution to the Equation (10) is Figure 9 . In Table   B In the Benign cancer situation, the cancer cells continue to grow and the immune cells deplete and led immune collapse. In order to control the cancer growth the immune system needs to be constantly replenished. Figure 9 . Solution of tumour cells using the logistic model.
In Figure 10 and Figure 11 the tumour cells continue to grow with corresponding growth from the immune cells r 1 (t) and r 2 (t) while r 3 (t) is fairly constant throughout the period of simulation.
Case IV: Malignant Cancer case wherein the tumour spread around the surrounding areas.
For this case, we consider the model ( ) 
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Solving the first equation in the Equation (11) 
Imposing initial condition we get
From the above equations, we observed that ( ) 
Sensitivity Analysis
We investigate the sensitivity of body. This is the most dangerous situation.
The equilibrium points for the Equation (11) are found to be The Solution to the Equation (11) Separating the last two equations in the Equation (9) we have ( ) 
Adding the last two equations in the Equation (9) 
while ( ) ( In order to avoid complication in evaluating ( ) , c t x when ( ) , r t x is substituted in the Equation (11) .
We obtain asymptotic approximation of ( ) 
To obtain solution ( ) , C t x in the Equation (9) is generally difficult hence we will rather consider the case when 1 n = . We assume that ( ) 
for large value of x.
Next we substitute the values of ( ) , r t x and ( ) , C t x in the Equation (11) to investigate the behaviour of ( ) , N t x . However, we can show that the solution to the Equation (11) is well poised in this dispensation. To solve the first and the second equations in the Equation (11) is very difficult in general, but by energy method we show that the system is stable when it existed in low energy state.
We define the energy function for the system as and from the first two equations in the Equation (11) we have 
where ( )
Hence rearrange the Equation (26) in terms of N and r we get Care must be taken not to affect other normal cells in the body.
Conclusion
Treatment or eradication of malignant cancer is one of the topmost challenging medical problems in the world today. The reason is anchor on fact that when cancer reaches metastases it spreads through the circulatory and lymphatic systems and cannot easily be rooted out. In this paper five models are considered to study the dynamic evolution of tumour and cancer cells in the presence of immune cells. The tumour and the cancer cells display out of control growth and hence unstable in nature and depreciated the immune cells to the point of immune collapse. By the use of energy function we established that staving of cancer cells of oxygen will prevent metabolic activities of the cancer cells to take place and hence this is a strategic way of combating cancer disease. Moreover, when the cancer cells of basic nutrients or some basic enzymes of the cancer cells are inhibited we expect that similar effect. To achieve this noble goal in practice is an open problem. However, we are optimistic that drugs developers and bioengineers will come up with means to achieve the starvation strategies to combat cancer disease. In general, starvation should focus on oxygen, nutrients and vital enzymes inhibition.
